Healthcare provider profile · identity verified

Scott C Bledsoe, D.O.

Family Practice · BRENTWOOD, CA · NPI 1275587586

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	736	353
Amlodipine Besylate	Amlodipine Besylate	637	293
Losartan Potassium	Losartan Potassium	522	230
Lisinopril	Lisinopril	338	159
Rosuvastatin Calcium	Rosuvastatin Calcium	310	144
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	308	96
Levothyroxine Sodium	Levothyroxine Sodium	296	129
Omeprazole	Omeprazole	287	136
Trazodone Hcl	Trazodone Hcl	220	99
Metformin Hcl	Metformin Hcl	219	101
Metformin Hcl Er	Metformin Hcl	216	105
Hydrochlorothiazide	Hydrochlorothiazide	202	95
Simvastatin	Simvastatin	201	98
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	181	99
Meloxicam	Meloxicam	177	104
Tamsulosin Hcl	Tamsulosin Hcl	176	74
Metoprolol Tartrate	Metoprolol Tartrate	175	80
Albuterol Sulfate Hfa	Albuterol Sulfate	167	110
Glipizide	Glipizide	166	82
Atenolol	Atenolol	154	67
Gabapentin	Gabapentin	151	81
Potassium Chloride	Potassium Chloride	148	88
Hydralazine Hcl	Hydralazine Hcl	143	75
Pantoprazole Sodium	Pantoprazole Sodium	142	61
Furosemide	Furosemide	140	70
Ibuprofen	Ibuprofen	119	52
Alendronate Sodium	Alendronate Sodium	115	51
Ozempic	Semaglutide	108	30
Lorazepam	Lorazepam	100	35
Jardiance	Empagliflozin	98	43
Pradaxa	Dabigatran Etexilate Mesylate	95	37
Finasteride	Finasteride	92	33
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	87	37
Terazosin Hcl	Terazosin Hcl	86	39
Prednisone	Prednisone	82	73
Allopurinol	Allopurinol	79	38
Naproxen	Naproxen	77	38
Tramadol Hcl	Tramadol Hcl	76	26
Acetaminophen-Codeine	Acetaminophen With Codeine	74	39
Mirtazapine	Mirtazapine	73	32
Azithromycin	Azithromycin	71	62
Bisoprolol Fumarate	Bisoprolol Fumarate	64	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	28
Clopidogrel	Clopidogrel Bisulfate	60	29
Lovastatin	Lovastatin	60	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	27
Famotidine	Famotidine	54	29
Hydrocortisone	Hydrocortisone	52	25
Carvedilol	Carvedilol	49	20
Fluocinonide	Fluocinonide	49	24
Duloxetine Hcl	Duloxetine Hcl	47	24
Cefadroxil	Cefadroxil	45	39
Ondansetron Odt	Ondansetron	43	24
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	17
Lactulose	Lactulose	42	23
Temazepam	Temazepam	42	14
Pioglitazone Hcl	Pioglitazone Hcl	41	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Trospium Chloride	Trospium Chloride	40	22
Spiriva Respimat	Tiotropium Bromide	39	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	36	22
Chlorhexidine Gluconate	Chlorhexidine Gluconate	35	suppressed
Mupirocin	Mupirocin	35	14
Azelastine Hcl	Azelastine Hcl	34	17
Fluoxetine Hcl	Fluoxetine Hcl	34	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	29
Eliquis	Apixaban	33	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	33	12
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Alprazolam	Alprazolam	32	13
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	31	30
Propranolol Hcl	Propranolol Hcl	31	12
Sertraline Hcl	Sertraline Hcl	31	18
Humulin N	Insulin Nph Human Isophane	30	13
Ezetimibe	Ezetimibe	29	19
Montelukast Sodium	Montelukast Sodium	29	12
Varenicline Tartrate	Varenicline Tartrate	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	15
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	28	14
Xarelto	Rivaroxaban	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	26
Ipratropium Bromide	Ipratropium Bromide	27	18
Fenofibrate	Fenofibrate	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	11
Fluconazole	Fluconazole	25	13
Nortriptyline Hcl	Nortriptyline Hcl	25	13
Sumatriptan Succinate	Sumatriptan Succinate	25	16
Buspirone Hcl	Buspirone Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	13
Pregabalin	Pregabalin	23	suppressed
Spironolactone	Spironolactone	21	15
Sucralfate	Sucralfate	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	17
Valacyclovir	Valacyclovir Hcl	21	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	21	11
Wixela Inhub	Fluticasone Propion/Salmeterol	21	13
Clonazepam	Clonazepam	20	suppressed
Colchicine	Colchicine	20	13
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Naloxone Hcl	Naloxone Hcl	19	11
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Tradjenta	Linagliptin	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Valsartan	Valsartan	14	suppressed
Alvesco	Ciclesonide	13	11
Bupropion Xl	Bupropion Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	13	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	11
Digoxin	Digoxin	12	suppressed
Metoprolol Succinate	Metoprolol Succinate	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Glimepiride	Glimepiride	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Moxifloxacin	Moxifloxacin Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error